The Research and Development team at AbelZeta is dedicated to the innovation and advancement of cell-based therapeutic products. This diverse team of scientists and specialists engages in process development, quality control, translational medicine, and regulatory program management to drive early-stage clinical studies and develop cutting-edge CAR-T and TIL therapies. Their work is pivotal in transforming scientific discoveries into viable treatments for hematological malignancies, solid tumors, and immunological diseases.